NCT07267026
- Conditions
- FSGS, MCD, Macular dystrophy, corneal type 1
- Locations
-
- Q-Pharm Pty Ltd. Herston, Queensland, Australia
Clinical trial condition
Explore clinical trials studying FSGS. Study availability and eligibility vary by location and protocol.
NCT07267026
NCT07213960
NCT06983028
NCT04571658
NCT05650619
NCT05183646
NCT05505500
NCT05508009
NCT02683889
NCT03536754